Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
M&A activity
confidence 92%
filed 2026-05-21
The filing discloses entry into a Fully Binding Letter of Intent (Term Sheet) dated May 20, 2026, involving a material multi-party transaction. The Company would acquire or license intellectual property from EOS and SCLX, expand its Datavault license, and acquire a controlling interest in Health Lives Here from HBA. Upon conversion of Acquisition Preferred, the transaction parties would own approximately 89.6% of the Company's common stock, representing a substantial change of control. The proposed combined entity valuation is stated at $4.0 billion. While subject to definitive agreements and conditions, this constitutes entry into a material definitive agreement for M&A activity under Item 1.01.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-21
Co-Diagnostics entered into a private placement on May 19, 2026, issuing 54,915 shares of common stock, 1,592,532 pre-funded warrants, and 3,294,894 common warrants for aggregate gross proceeds of $3.0 million. The filing explicitly discloses the Securities Purchase Agreement with institutional and accredited investors, detailed warrant terms, and registration rights obligations. This is a classic dilutive equity issuance (PIPE-like structure with warrants) that materially affects shareholder ownership and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-21
Jupiter Neurosciences entered into a Securities Purchase Agreement on May 20, 2026, to issue 7,142,858 shares of common stock at $0.28 per share in a registered direct offering, raising approximately $2.0 million in gross proceeds. This is a registered equity issuance that will dilute existing shareholders and is material to investors assessing the company's capital structure and financing activities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-21
The filing discloses Item 5.07 results from Landmark Bancorp's Annual Meeting of Stockholders held May 20, 2026, including voting outcomes on three proposals: election of three Class I directors (Angela S. Hurt, David H. Snapp, and Angelia K. Stanland), approval of an amendment to increase authorized common shares from 7.5M to 10M, and ratification of Forvis Mazars, LLP as independent auditor. These are standard shareholder vote results that materially affect corporate governance and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-21
Item 3.02
AIM ImmunoTech completed an unregistered private placement of Common Warrants and Placement Agent Warrants under Section 4(a)(2) and Rule 506, with pricing announced on May 20, 2026. The offering included a Securities Purchase Agreement and underlying shares, representing a dilutive equity issuance to accredited investors that materially affects shareholder ownership and capital structure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-21
The 8-K discloses Item 2.02 (Results of Operations and Financial Condition), with I-ON Digital Corp. issuing a press release on May 21, 2026 announcing financial results for the first quarter ended March 31, 2026. The press release is attached as Exhibit 99.1. This is a standard earnings release disclosure that would materially affect a reasonable investor's assessment of the registrant's financial performance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a clear disclosure of shareholder vote results from Steven Madden's 2026 Annual Meeting of Stockholders held on May 20, 2026. The filing reports the final voting tallies for three proposals: election of ten directors, ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote counts (For, Against, Withheld, Abstentions, Broker Non-Votes) for each proposal are the hallmark of Item 5.07 disclosures and constitute material information about corporate governance outcomes.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-05-21
The filing discloses the appointment of Ronen Tanami as Chief Operating Officer on May 13, 2026, which is the principal action reported. While the Item 5.02 disclosure also includes compensatory details (a 40,000-share option grant), the core event is the executive appointment. The appointment of a COO is material to investors as it reflects a significant change in the company's management structure.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
The filing discloses under Item 8.01 (Other Events) that Ocean Power Technologies announced an expansion in its global deployment footprint across U.S. government, international, and research customers via press release. While the specific details of the expansion are not provided in the 8-K body itself, the announcement of expanded deployment across government and international customers could be material to investors assessing the company's growth trajectory and market reach. However, without the full press release text, the precise materiality and nature of the event cannot be definitively categorized into a more specific event type, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-21
The filing discloses the Board's appointment of Taehoon Kim, the current CEO, to the additional roles of Principal Financial Officer and Principal Accounting Officer, effective immediately on May 18, 2026. This is a material executive appointment that consolidates critical financial and accounting oversight functions under the CEO following the previously announced resignation of CFO Juhyon Shin. The appointment of a principal financial officer is a material event affecting investor assessment of the company's financial governance and leadership structure.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
The filing discloses a shareholder letter regarding "strategy overview and business update" under Item 8.01 (Other Events). Without access to the actual letter content (Exhibit 99.1), the materiality and specific nature of the update cannot be determined with certainty. However, a formal shareholder letter on strategy and business update filed via 8-K suggests material developments that would affect investor assessment, warranting classification as other_material rather than a more specific event type.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-05-21
The filing discloses entry into a Share Exchange Agreement on May 15, 2026, whereby the Company's subsidiary Yingxi acquires 41.67% equity interest in Riches Family Office Limited in exchange for issuance of 33,500 common shares to the Company's Chief Operating Officer. This constitutes a material acquisition activity under Item 1.01, with related-party transaction approval by the audit committee and board. The transaction involves a valuation report and is subject to Nasdaq listing notification, indicating materiality to investors.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-05-21
The filing discloses the resignations of three senior executives effective immediately or June 15, 2026: Lyron Bentovim (CEO and Board Chair), Maydan Rothblum (CFO, COO, Secretary, Treasurer), and Jeff Enslin (Director). The departure of the CEO and CFO represents a material change in executive leadership that would affect a reasonable investor's assessment of the company. While the filing also mentions expected appointments (Tyler Gates as CEO), the principal disclosed action centers on the departures of key officers.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
The filing discloses that ARC Group Acquisition I Corp announced the commencement of separate trading of its unit components (Class A ordinary shares, warrants, and rights) on NASDAQ effective May 28, 2026. This is a structural capital markets event following the company's recent IPO completion (May 5-7, 2026), but does not fit neatly into the standard taxonomy categories. While material to investors as it affects trading mechanics and liquidity of the company's securities, it is neither an earnings release, executive change, M&A activity, nor a financial restatement or impairment.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-21
HCW Biologics disclosed entry into a Securities Purchase Agreement on May 21, 2026, for the unregistered sale of 2,846,975 units comprising common shares, pre-funded warrants, and common warrants, raising approximately $4.0 million in gross proceeds. The filing explicitly invokes Item 1.01 (Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), with securities issued under Section 4(a)(2) and Regulation D Rule 506(b). This is a classic private placement (PIPE-like) dilutive issuance to accredited investors.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-05-21
Item 5.02
The filing discloses amendments to employment agreements for Michael Winston (Executive Chairman and Interim CEO) and George Murnane (Interim CFO) that materially modify their compensatory arrangements and restrictive covenants. The amendments extend non-compete and non-solicitation periods from one to two years, introduce a new clawback provision for incentive-based compensation and bonuses, and provide $1,000 one-time bonuses in exchange for covenant compliance. These modifications to executive compensation terms and incentive structures are the principal disclosed action, making this an exec_compensation event rather than a departure or appointment.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-05-21
The filing discloses that Algorhythm Holdings received a Nasdaq delisting notice on November 28, 2025 for failing to maintain the required $2.5 million stockholders' equity under Listing Rule 5550(b)(1), and while the company claims to have regained compliance as of March 31, 2026, Nasdaq explicitly warned that "if at the time of its next periodic report the Company does not evidence compliance, the Company may be subject to delisting." This is a material delisting risk disclosure under Item 8.01.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-05-21
SharonAI Holdings issued $350 million of 6.00% Convertible Senior Notes due 2031 to qualified institutional buyers on May 18, 2026. The Notes are convertible into up to 8.7 million shares of Common Stock (or 11.3 million if accrued interest is converted), representing a significant dilutive issuance. While this is technically a debt offering, the convertible feature and the substantial equity dilution potential (conversion price of $48.24 per share, approximately 20% premium to Nasdaq Minimum Price) make this a material capital-raising event with substantial dilution implications for existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-21
The filing discloses an underwritten public offering of 16,778,524 shares of common stock at $8.94 per share, with expected net proceeds of approximately $140.65 million. This is a material dilutive equity issuance that would significantly affect existing shareholders' ownership percentages and is disclosed under Item 8.01 (Other Events) with an underwriting agreement and prospectus supplement filed pursuant to Rule 424(b)(5).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a clear disclosure of shareholder vote results from Summit Hotel Properties' Annual Meeting of Stockholders held on May 20, 2026. The filing reports the outcomes of three proposals: election of eight directors, ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All proposals passed with substantial majorities, and the detailed voting tallies (For/Against/Abstain/Broker Non-Votes) are provided for each matter, which is the hallmark of Item 5.07 disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
BankUnited held its Annual Meeting on May 21, 2026, with shareholders voting on four proposals: election of nine directors, ratification of Deloitte & Touche LLP as auditor, advisory approval of named executive officer compensation, and approval of the Amended and Restated 2023 Omnibus Equity Incentive Plan. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This Item 5.07 filing discloses the results of Voya Financial's Annual Meeting of Stockholders held on May 21, 2026, including three matters voted upon: election of twelve directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The tabulated voting results for each matter are presented with vote counts (For, Against, Abstentions, and Broker Non-Votes), which is the core disclosure required under Item 5.07.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 8.01
This Item 8.01 discloses the issuance and sale of approximately $472.9 million in commercial mortgage pass-through certificates by BBCMS Mortgage Trust 2026-5C41, a securitization vehicle. While the filing describes the transaction structure, underwriters, and credit risk retention compliance under Regulation RR, it does not fit neatly into the standard 8-K event taxonomy (e.g., not an earnings release, M&A activity, restatement, or going-concern disclosure). The transaction is material to investors in the certificates and the registrant's stakeholders, but the disclosure is primarily informational about a completed securitization closing rather than a discrete corporate event triggering a specific Item category.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a clear disclosure of shareholder vote results from First Community Corporation's annual meeting held May 20, 2026. The filing reports voting outcomes on three matters: election of nine directors across three classes, an advisory say-on-pay vote, and ratification of Elliott Davis, LLC as independent auditor. The detailed vote tallies (For, Against, Withheld, Broker Non-Vote) for each director candidate and proposal are the hallmark of Item 5.07 disclosure and are material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a clear disclosure of shareholder voting results from EVERTEC's 2026 Annual Meeting of Stockholders held on May 21, 2026. The filing presents detailed voting tallies for three proposals: election of ten directors, an advisory vote on executive compensation, and ratification of Deloitte & Touche LLP as independent auditor. This is the quintessential shareholder_vote_results event type under Item 5.07, and the outcomes are material to investors as they confirm board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This Item 5.07 disclosure presents the complete voting results from Constellium SE's Annual General Meeting of Shareholders held on May 21, 2026, covering 16 proposals including director appointments (Ingrid Joerg and John Ormerod), advisory compensation votes, financial statement approvals, and share repurchase authorizations. The detailed tabulation of votes cast for, against, and abstained on each proposal is the hallmark of shareholder vote results disclosure required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a clear disclosure of shareholder vote results from the Company's Annual Meeting of Stockholders held on May 19, 2026, covering four proposals: election of seven directors, ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the Fourth Amended and Restated 2013 Incentive Award Plan. The filing presents detailed voting tallies for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures and is material to investors assessing corporate governance and executive compensation matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Sprouts Farmers Market's May 20, 2026 annual meeting. The filing presents final voting tallies for four proposals: election of two Class I directors (Joel D. Anderson and Terri Funk Graham both duly elected), advisory approval of named executive officer compensation (approved), say-on-frequency vote (one year prevailed), and ratification of PricewaterhouseCoopers LLP as auditor (approved). All proposals passed with substantial majorities, making this a material governance event that investors rely upon to assess board composition and compensation oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a clear disclosure of shareholder voting results from SiriusPoint Ltd's 2026 annual general meeting held on May 20, 2026, covering four proposals: election of two Class I directors, advisory approval of named executive officer compensation, appointment of PricewaterhouseCoopers LLP as independent auditor, and approval of the SiriusPoint SharePlan. The tabulated voting results for each proposal are presented with vote counts (For, Against, Abstain, Broker Non-Votes), which is the hallmark of Item 5.07 disclosure and the shareholder_vote_results event type.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-21
Item 2.02
The filing discloses a press release announcing financial results for the three months ended April 30, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). This is a standard quarterly earnings release, which is material to investors as it provides key financial performance metrics and operational updates.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a clear disclosure of shareholder vote results from Via Transportation's 2026 Annual Meeting of Stockholders held on May 18, 2026. The filing reports voting outcomes for two proposals: election of two Class I directors (Arnon Dinur and Nechemia Peres) and ratification of Deloitte & Touche LLP as independent auditor, with detailed vote tallies for each. This is the quintessential shareholder_vote_results event type under Item 5.07.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-21
Item 2.02
Advanced Drainage Systems disclosed unaudited financial results for the fourth quarter and fiscal year ended March 31, 2026 via press release (Exhibit 99.1) and announced a conference call with presentation slides (Exhibit 99.2) where management will discuss the results.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
Item 8.01
The Board of Directors approved a cash dividend of $0.20 per share payable on June 15, 2026.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-21
Item 7.01
The disclosure describes a "Segment Realignment" following the NDS acquisition, where ADS consolidated reportable segments from "Infiltrator" into "Stormwater and Wastewater" and changed the profitability metric from adjusted gross profit to Adjusted EBITDA. While segment restatements and metric changes are material to investors assessing operational performance, this does not fit the specific restatement category (Item 4.02 language is absent—the company explicitly states it "does not amend or restate any of the Company's previously issued financial statements"). The realignment is disclosed under Item 7.01 (Regulation FD Disclosure) as supplemental information, making it a material disclosure that falls outside the more specific event categories.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 annual meeting held on May 20, 2026, covering four proposals: election of seven directors, advisory approval of named executive officer compensation, frequency of advisory compensation votes, and ratification of BDO USA, P.C. as independent auditor. The filing explicitly presents voting tallies for each proposal, which is the hallmark of Item 5.07 shareholder_vote_results disclosures and is material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-21
Item 1.01
Talen Energy amended its credit agreement on May 20, 2026, repricing three facilities totaling approximately $2.585 billion (Initial Term B: $846M, 2024-1 Incremental Term B: $839M, Revolving: $900M) and extending the maturity of the Initial Term B Facility from May 2030 to November 2032. While this is a material definitive agreement under Item 1.01, it does not fit cleanly into the M&A activity category—it is a refinancing/repricing of existing debt rather than an acquisition, disposition, merger, or change of control. The amendment reduces interest margins (ABR margin from unspecified to 0.75%/0.50%, Term SOFR margin to 1.75%/1.50%) and extends maturity, which is material to investors assessing the company's capital structure and debt obligations, but the event is primarily a debt restructuring rather than a discrete M&A transaction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-21
Item 5.02
Teresa Chia was appointed to the Board of Directors effective May 22, 2026, as an independent director and Audit Committee member, filling a vacancy created by Jennifer Ceran's non-re-election.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
Shareholders voted at the 2026 Annual Meeting on May 21, 2026, approving the election of four directors (Tim Chen, Lynne M. Laube, Anthony Ling, and Kenneth T. McBride) and ratifying Deloitte & Touche LLP as the independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of ThredUp's 2026 Annual Meeting of Stockholders held on May 20, 2026. The filing presents voting results for two proposals: election of three Class II directors (James Reinhart, Dan Nova, and Kelly Bodnar Battles) and ratification of Deloitte & Touche LLP as independent auditor. All three director nominees and the auditor ratification passed with substantial majorities. Shareholder voting outcomes are material to investors as they determine corporate governance composition and audit oversight.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-21
Item 7.01
Dream Finders Homes issued a press release on May 21, 2026 disclosing a proposal to acquire all outstanding shares of Beazer Homes USA, Inc. in an all-cash transaction. This constitutes entry into material acquisition activity, which would materially affect a reasonable investor's assessment of the registrant's strategic direction and financial obligations. The disclosure explicitly references the proposed business combination transaction and includes forward-looking statements regarding synergies and integration.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-21
Item 1.01
HawkEye 360 entered into a $125 million senior secured revolving credit facility on May 19, 2026, a material capital structure event that includes significant financial covenants (leverage and interest coverage ratios) and customary events of default.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-21
Item 1.02
HawkEye 360 terminated two material loan agreements (Senior Term Loan with Silicon Valley Bank and Mezzanine Loan with First-Citizens Bank) following full repayment on May 18, 2026, with release of all security interests, representing a significant deleveraging event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-05-21
Item 2.02
Ralph Lauren Corporation disclosed its fiscal year ended March 28, 2026 results of operations under Item 2.02, with a press release furnished as Exhibit 99.1. This is a standard annual earnings release disclosure, which is material to investors as it provides comprehensive financial performance information for the fiscal year.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
American States Water held its annual shareholder meeting on May 19, 2026, with voting results on four matters: election of Class III directors (Eichelberger, Ervin, and Levin), approval of the 2026 Stock Incentive Plan, an advisory vote on named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. All matters passed with substantial majorities.
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 85%
filed 2026-05-21
Item 1.01
The Twelfth Amendment to the credit facility waives noncompliance with minimum unrestricted cash, minimum consolidated EBITDA, and minimum sell-side revenue financial covenants for Q1 2026, as well as nonpayment of interest for April 2026. The amendment tightens the EBITDA covenant to $200,000 minimum for Q2 2026, signaling lender concern about the borrower's ability to maintain compliance.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-21
Item 8.01
The company disclosed a material change in reportable segments from two segments (buy-side and sell-side) to one consolidated digital marketing segment, and implemented a 4-to-1 reverse stock split effective April 27, 2026. The segment restructuring and recast financial statements materially affect investors' understanding of the company's operational structure and historical financial performance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-21
Item 1.01
Blue Owl Capital Corporation entered into an Eleventh Supplemental Indenture on May 21, 2026, for the issuance of $400 million in 6.300% notes due 2031. The company intends to use proceeds to pay down existing indebtedness, representing a material refinancing and capital structure event.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 82%
filed 2026-05-21
Item 1.01
QT Imaging Holdings entered into an underwriting agreement on May 15, 2026, for a registered public offering of 1,200,000 common shares at $5.00 per share and 800,000 pre-funded warrants at $4.9999 per warrant, raising approximately $9 million in net proceeds. The pre-funded warrant structure—exercisable at $0.0001 per share—creates substantial dilution typical of small-cap companies in financial stress.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-21
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Finance of America Companies Inc.'s Annual Meeting of Stockholders held on May 15, 2026. The filing presents voting outcomes for three proposals: election of six directors, advisory vote on named executive officer compensation, and ratification of BDO USA, P.C. as independent auditor. The detailed vote tallies (votes for, against, withheld, abstentions, and broker non-votes) are the core content of the disclosure, making this unambiguously a shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-21
Item 5.07
This is a clear disclosure of shareholder vote results under Item 5.07. CRH held two separate scheme meetings on May 21, 2026 for holders of the 7% "A" cumulative preference shares and 5% cumulative preference shares, with detailed voting tallies showing approval of the cancellation of each class of shares. The cancellation of preference shares is a material capital structure event affecting security holders.
View raw filing on EDGAR →